Stratos Wealth Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,816
Closed -$240K 724
2024
Q3
$240K Sell
3,816
-3,062
-45% -$179K 0.01% 665
2024
Q2
$406K Buy
6,878
+1,054
+18% +$65.9K 0.02% 517
2024
Q1
$465K Sell
5,824
-1,825
-24% -$139K 0.03% 471
2023
Q4
$604K Buy
7,649
+1,035
+16% +$73.7K 0.03% 428
2023
Q3
$462K Buy
6,614
+2,990
+83% +$212K 0.03% 441
2023
Q2
$251K Sell
3,624
-1,260
-26% -$89.7K 0.02% 557
2023
Q1
$363K Sell
4,884
-773
-14% -$64.8K 0.03% 464
2022
Q4
$527K Buy
5,657
+443
+8% +$42.7K 0.04% 390
2022
Q3
$497K Sell
5,214
-1,045
-17% -$103K 0.05% 356
2022
Q2
$580K Sell
6,259
-1,401
-18% -$137K 0.05% 338
2022
Q1
$775K Buy
7,660
+27
+0.4% +$2.84K 0.06% 316
2021
Q4
$787K Buy
7,633
+1,623
+27% +$150K 0.06% 318
2021
Q3
$510K Sell
6,010
-1,572
-21% -$132K 0.04% 352
2021
Q2
$633K Buy
7,582
+238
+3% +$19.5K 0.06% 317
2021
Q1
$552K Buy
7,344
+3,179
+76% +$232K 0.06% 299
2020
Q4
$285K Buy
+4,165
New +$271K 0.04% 325
2019
Q4
Sell
-4,397
Closed -$277K 186
2019
Q3
$277K Buy
+4,397
New +$261K 0.11% 192

Other funds holding CVS

Stratos Wealth Advisors's CVS Position: Q4 2024 in Review

Stratos Wealth Advisors sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,816 shares — an estimated $240K sold.

Stratos Wealth Advisors first reported a position in CVS in Q3 2019 and held it in 17 quarters. The position peaked at $787K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Stratos Wealth Advisors reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Stratos Wealth Advisors sold 3,816 CVS Health shares in Q4 2024, an estimated $240K.
  • Stratos Wealth Advisors first reported a position in CVS Health in Q3 2019 and held it in 17 quarters.
  • Stratos Wealth Advisors's CVS Health position peaked at $787K in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Stratos Wealth Advisors's 13F filing for Q4 2024, filed 27 Jan 2025.